All EMS presentations
RespiratoryClinical presentation

COPD exacerbation

A streamlined, differential-led presentation for rapid clinical review.

Clinical snapshot

Twenty-second review

  • COPD exacerbation increases airflow obstruction, gas trapping, work of breathing, ventilation-perfusion mismatch, and risk of fatigue or hypercapnic failure.
  • Silent chest, exhaustion, confusion, cyanosis, hypotension, new chest pain, or poor response to usual therapy requires escalation.
  • Keep anxiety or medication effect in the differential; overlapping or concurrent illness remains possible.
  • For copd exacerbation, trends and combinations of findings are more informative than one isolated vital sign.
Differentials

Compare the clinical patterns

The repeated material is grouped inside each possibility. Open only the condition you need.

Serious5 conditions
PneumoniaTime-sensitive high-risk possibility

HPI

Clarify baseline respiratory status and spo2/o2; change from baseline; increased/change in sputum.

Signs & symptoms

Focal, sudden, pleuritic, ischemic, or congestive clues widen the differential.

Focused exam

Observe position, speech, accessory-muscle use, pattern, depth, and chest symmetry; Auscultate all lung fields and reassess after movement or treatment.

Brief pathophysiology

Pneumonia may cause copd exacerbation through a time-sensitive process capable of rapid physiological deterioration.

Vital-sign pattern

What the trend may show

Possible pattern

Respiratory infection may impair oxygenation and trigger systemic illness. Older or immunocompromised patients may lack fever, so trend all four observations and mental status.

Respiratory rate (breaths/min)

Often rises

Tachypnea can be an early marker of respiratory or systemic illness.

Oxygen saturation (SpO₂)

May fall

Parenchymal disease can impair gas exchange; compare with baseline.

Temperature (°C)

May rise or fall

Fever is common, but normal or low temperature does not exclude serious infection.

Heart rate (bpm)

Often rises

Tachycardia may reflect fever, hypoxia, dehydration, or sepsis.

Front-load in the triage report

  • Pneumonia: Focal, sudden, pleuritic, ischemic, or congestive clues widen the differential.
  • Baseline respiratory status and SpO2/O2.
  • Change from baseline.
PETime-sensitive high-risk possibility

HPI

Clarify change from baseline; increased/change in sputum; fever.

Signs & symptoms

Focal, sudden, pleuritic, ischemic, or congestive clues widen the differential.

Focused exam

Auscultate all lung fields and reassess after movement or treatment; Assess speech, accessory muscles, air entry, wheeze, prolonged expiration, baseline oxygen, sputum, edema, and fever.

Brief pathophysiology

PE may cause copd exacerbation through a time-sensitive process capable of rapid physiological deterioration.

Vital-sign pattern

What the trend may show

Possible pattern

Pulmonary embolism may have normal observations. Tachycardia, tachypnea, or hypoxemia increase concern; hypotension identifies hemodynamic compromise rather than being required for diagnosis.

Heart rate (bpm)

May rise

Tachycardia is common but neither sensitive nor specific.

Respiratory rate (breaths/min)

May rise

Tachypnea may be an early sign of increased ventilatory demand.

Oxygen saturation (SpO₂)

May fall

Hypoxemia may occur, but a normal saturation does not exclude PE.

Blood pressure (mmHg)

Often preserved

Hypotension suggests high-risk PE with obstructive shock.

Front-load in the triage report

  • PE: Focal, sudden, pleuritic, ischemic, or congestive clues widen the differential.
  • Change from baseline.
  • Increased/change in sputum.
PneumothoraxTime-sensitive high-risk possibility

HPI

Clarify increased/change in sputum; fever; wheeze vs diminished sounds.

Signs & symptoms

Focal, sudden, pleuritic, ischemic, or congestive clues widen the differential.

Focused exam

Auscultate all lung fields and reassess after movement or treatment; Assess speech, accessory muscles, air entry, wheeze, prolonged expiration, baseline oxygen, sputum, edema, and fever.

Brief pathophysiology

Pneumothorax may cause copd exacerbation through a time-sensitive process capable of rapid physiological deterioration.

Vital-sign pattern

What the trend may show

Possible pattern

Thoracic injury can evolve from respiratory compromise to obstructive or hemorrhagic shock. Integrate symmetry, air entry, work of breathing, and perfusion with serial observations.

Respiratory rate (breaths/min)

Often rises

Tachypnea commonly reflects pain, hypoxemia, or impaired mechanics.

Oxygen saturation (SpO₂)

May fall

Desaturation supports significant gas-exchange impairment but may lag.

Heart rate (bpm)

Often rises

Tachycardia may accompany distress, hypoxia, or shock.

Blood pressure (mmHg)

May fall late

Hypotension raises concern for tension physiology or significant hemorrhage.

Front-load in the triage report

  • Pneumothorax: Focal, sudden, pleuritic, ischemic, or congestive clues widen the differential.
  • Increased/change in sputum.
  • Fever.
ACSTime-sensitive high-risk possibility

HPI

Clarify fever; wheeze vs diminished sounds; current work of breathing.

Signs & symptoms

Focal, sudden, pleuritic, ischemic, or congestive clues widen the differential.

Focused exam

Auscultate all lung fields and reassess after movement or treatment; Assess speech, accessory muscles, air entry, wheeze, prolonged expiration, baseline oxygen, sputum, edema, and fever.

Brief pathophysiology

ACS may cause copd exacerbation through a time-sensitive process capable of rapid physiological deterioration.

Vital-sign pattern

What the trend may show

Possible pattern

Acute coronary syndrome frequently presents without a diagnostic vital-sign pattern. Abnormal observations suggest complications; normal observations do not exclude ischemia.

Blood pressure (mmHg)

High, normal, or low

Pain may elevate pressure; hypotension suggests major infarction or complication.

Heart rate (bpm)

High, normal, or low

Ischemia, conduction disturbance, medication, and autonomic response all affect rate.

Respiratory rate (breaths/min)

May rise

Tachypnea can reflect pain, heart failure, or shock.

Oxygen saturation (SpO₂)

Often preserved

Low SpO₂ suggests pulmonary edema or concurrent respiratory disease; normal does not exclude ACS.

Front-load in the triage report

  • ACS: Focal, sudden, pleuritic, ischemic, or congestive clues widen the differential.
  • Fever.
  • Wheeze vs diminished sounds.
Acute heart failureTime-sensitive high-risk possibility

HPI

Clarify wheeze vs diminished sounds; current work of breathing; previous icu/intubation.

Signs & symptoms

Focal, sudden, pleuritic, ischemic, or congestive clues widen the differential.

Focused exam

Auscultate all lung fields and reassess after movement or treatment; Assess speech, accessory muscles, air entry, wheeze, prolonged expiration, baseline oxygen, sputum, edema, and fever.

Brief pathophysiology

Acute heart failure may cause copd exacerbation through a time-sensitive process capable of rapid physiological deterioration.

Vital-sign pattern

What the trend may show

Possible pattern

Acute heart failure usually presents as respiratory distress with impaired oxygenation; blood pressure may be high, normal, or low and materially changes management and risk.

Respiratory rate (breaths/min)

Usually rises

Tachypnea and increased work of breathing are common.

Oxygen saturation (SpO₂)

May fall

Pulmonary edema can impair gas exchange.

Blood pressure (mmHg)

High, normal, or low

Hypertension is common, while hypotension suggests poor forward flow or cardiogenic shock.

Heart rate (bpm)

Often rises

Tachycardia is common but rate-limiting drugs or conduction disease may blunt it.

Front-load in the triage report

  • Acute heart failure: Focal, sudden, pleuritic, ischemic, or congestive clues widen the differential.
  • Wheeze vs diminished sounds.
  • Current work of breathing.
Common1 condition
COPD exacerbationCommon presentation pattern

HPI

Clarify baseline respiratory status and spo2/o2; change from baseline; increased/change in sputum.

Signs & symptoms

Increased dyspnea, cough, sputum, wheeze, and known obstruction may fit.

Focused exam

Observe position, speech, accessory-muscle use, pattern, depth, and chest symmetry; Auscultate all lung fields and reassess after movement or treatment.

Brief pathophysiology

COPD exacerbation may explain the presenting symptoms through a common clinical mechanism, while serial assessment checks for complications or an alternate cause.

Vital-sign pattern

What the trend may show

Possible pattern

Compare with the patient’s baseline and prescribed oxygen target. In confirmed hypercapnic respiratory failure, an SpO₂ target of 88–92% may be appropriate under current guidance.

Respiratory rate (breaths/min)

Often rises

Tachypnea and increased work of breathing are common during exacerbation.

Oxygen saturation (SpO₂)

May be below 94%

Interpret against baseline and the patient-specific oxygen target.

Heart rate (bpm)

May rise

Tachycardia can reflect distress, hypoxemia, infection, or medication effect.

Temperature (°C)

Variable

Fever supports infection but its absence does not exclude an infectious trigger.

Front-load in the triage report

  • Increased dyspnea, cough, sputum, wheeze, and known obstruction may fit.
  • Baseline respiratory status and SpO2/O2.
  • Change from baseline.
Mimics2 conditions
AnxietyImportant alternative presentation

HPI

Clarify baseline respiratory status and spo2/o2; change from baseline; increased/change in sputum.

Signs & symptoms

May amplify symptoms but should not replace cardiopulmonary assessment.

Focused exam

Observe position, speech, accessory-muscle use, pattern, depth, and chest symmetry; Auscultate all lung fields and reassess after movement or treatment.

Brief pathophysiology

Anxiety can resemble copd exacerbation through overlapping symptoms or referred physiology despite a different primary mechanism.

Vital-sign pattern

What the trend may show

Possible pattern

Compare with the patient’s baseline and prescribed oxygen target. In confirmed hypercapnic respiratory failure, an SpO₂ target of 88–92% may be appropriate under current guidance.

Respiratory rate (breaths/min)

Often rises

Tachypnea and increased work of breathing are common during exacerbation.

Oxygen saturation (SpO₂)

May be below 94%

Interpret against baseline and the patient-specific oxygen target.

Heart rate (bpm)

May rise

Tachycardia can reflect distress, hypoxemia, infection, or medication effect.

Temperature (°C)

Variable

Fever supports infection but its absence does not exclude an infectious trigger.

Front-load in the triage report

  • May amplify symptoms but should not replace cardiopulmonary assessment.
  • Baseline respiratory status and SpO2/O2.
  • Change from baseline.
Medication effectImportant alternative presentation

HPI

Clarify change from baseline; increased/change in sputum; fever.

Signs & symptoms

May amplify symptoms but should not replace cardiopulmonary assessment.

Focused exam

Auscultate all lung fields and reassess after movement or treatment; Assess speech, accessory muscles, air entry, wheeze, prolonged expiration, baseline oxygen, sputum, edema, and fever.

Brief pathophysiology

Medication effect can resemble copd exacerbation through overlapping symptoms or referred physiology despite a different primary mechanism.

Vital-sign pattern

What the trend may show

Possible pattern

Compare with the patient’s baseline and prescribed oxygen target. In confirmed hypercapnic respiratory failure, an SpO₂ target of 88–92% may be appropriate under current guidance.

Respiratory rate (breaths/min)

Often rises

Tachypnea and increased work of breathing are common during exacerbation.

Oxygen saturation (SpO₂)

May be below 94%

Interpret against baseline and the patient-specific oxygen target.

Heart rate (bpm)

May rise

Tachycardia can reflect distress, hypoxemia, infection, or medication effect.

Temperature (°C)

Variable

Fever supports infection but its absence does not exclude an infectious trigger.

Front-load in the triage report

  • May amplify symptoms but should not replace cardiopulmonary assessment.
  • Change from baseline.
  • Increased/change in sputum.
Red flags

Findings that should escalate concern

  • Silent chest, exhaustion, confusion, cyanosis, hypotension, new chest pain, or poor response to usual therapy requires escalation.
  • Pneumonia, PE, pneumothorax, ACS, or acute heart failure: Focal, sudden, pleuritic, ischemic, or congestive clues widen the differential.
Related medications

Medication recognition

Related EMS presentations

Continue the clinical pathway

References

Clinical and academic sources

Curated clinical guidance and peer-reviewed evidence supporting this presentation. Current BCEHS guidance, medical direction, and local policy remain authoritative for practice.

BCEHS Handbook — specific CPGs

  1. B05: Chronic Obstructive Pulmonary DiseaseBC Emergency Health Services Handbook

    Official BCEHS clinical practice guidance for chronic obstructive pulmonary disease.

Supporting clinical and academic evidence

  1. CEDIS Presenting Complaint List updateCanadian Association of Emergency Physicians

    Presenting-complaint terminology and categorization context. It does not establish a prehospital “top 100” ranking.

  2. Guideline for oxygen use in adults in healthcare and emergency settingsBritish Thoracic Society

    Peer-reviewed guidance for oxygen assessment, targets, delivery, and monitoring in acute illness.

  3. Evaluation and Management of Asthma and COPD Exacerbation in the Emergency DepartmentEmergency Medicine Clinics of North America · 2022

    Differentiation, severity assessment, oxygenation, ventilation, and acute exacerbation management.